Observations using antiendotoxin antibody (E5) as adjuvant therapy in humans with suspected, serious, Gram-negative sepsis

Nursing and Health Professions

• Gram Negative Infection 100%
• Gram Negative Sepsis 100%
• Adjuvant Therapy 100%
• Placebo 60%
• Infection 40%
• Mortality Rate 40%
• Efficacy 40%
• University Hospital 20%
• Leukocyte Count 20%
• Surgical Intensive Care Unit 20%
• Medical Intensive Care Unit 20%
• Urine Volume 20%
• Adverse Event 20%
• Infusion 20%
• Vital Sign 20%
• Intensive Care Nursing 20%
• Placebo-Controlled Study 20%
• Immunoglobulin M Antibody 20%
• Edobacomab 20%
• Paraprotein 20%
• Immunoglobulin G 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Gram Negative Infection 100%
• Gram Negative Sepsis 100%
• Placebo 60%
• Mortality Rate 40%
• Infection 40%
• Adverse Event 20%
• Placebo-Controlled Study 20%
• Edobacomab 20%
• Immunoglobulin M Antibody 20%
• Paraprotein 20%
• Immunoglobulin G 20%